Mount Yale Investment Advisors’s PIMCO Enhanced Short Maturity Active Exchange-Traded Fund MINT Stock Holding History

Mount Yale Investment Advisors’s Portfolio MINT Stock Details MINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$463K	Buy	+4,594	New	+$462K	0.01%	809

Other funds holding MINT

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

Mount Yale Investment Advisors's MINT Position: Q2 2026 in Review

Mount Yale Investment Advisors opened a new position in PIMCO Enhanced Short Maturity Active Exchange-Traded Fund (MINT) in Q2 2026: 4,594 shares worth $463K. The stake represents 0.01% of the portfolio and ranks #809 among its holdings.

757 funds tracked by Wall St. Rank hold MINT as of Q2 2026.

Mount Yale Investment Advisors held 4,594 shares of PIMCO Enhanced Short Maturity Active Exchange-Traded Fund worth $463K as of Q2 2026.
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund was a new Mount Yale Investment Advisors position in Q2 2026.
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund made up 0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #809 holding.
757 funds tracked by Wall St. Rank held PIMCO Enhanced Short Maturity Active Exchange-Traded Fund as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.